Literature DB >> 11850848

p21B, a variant of p21(Waf1/Cip1), is induced by the p53 family.

Susan Nozell1, Xinbin Chen.   

Abstract

Alternative splicing or expression from an alternate promoter can produce variants of a gene. To determine whether the p21(Waf1/Cip1) locus is regulated by these mechanisms, we searched for and found two transcripts, p21B and p21C, that are expressed from an alternate promoter in the first intron of the p21 gene. While p21C encodes the p21 cyclin-dependent kinase inhibitor, p21B encodes a novel protein and the transcript is ubiquitously expressed in 16 human tissues tested. Like p21, both p21B and p21C are induced by DNA damage, p53, and other p53 family members through a proximal p53 response element in the promoter of p21B and p21C. However, unlike p21, which induces cell cycle arrest, we found that overexpression of p21B induces apoptosis. These findings indicate that the p21 locus expresses at least two structurally distinct, but functionally related, variants of the p21 gene from discrete promoters.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850848     DOI: 10.1038/sj.onc.1205191

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas.

Authors:  Xueyan Zhao; Travis Laver; Suk W Hong; George B Twitty; Annelies Devos; Marijke Devos; Etty N Benveniste; Susan E Nozell
Journal:  J Neurooncol       Date:  2011-01-30       Impact factor: 4.130

2.  The Roles of P53 and Its Family Proteins, P63 and P73, in the DNA Damage Stress Response in Organogenesis-Stage Mouse Embryos.

Authors:  Nazem El Husseini; Barbara F Hales
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

3.  Distinct p53 genomic binding patterns in normal and cancer-derived human cells.

Authors:  Krassimira Botcheva; Sean R McCorkle; W R McCombie; John J Dunn; Carl W Anderson
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

4.  Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression.

Authors:  Daniel P Jackson; Hui Li; Kristen A Mitchell; Aditya D Joshi; Cornelis J Elferink
Journal:  Mol Pharmacol       Date:  2014-01-15       Impact factor: 4.436

5.  Establishment of a dog model for the p53 family pathway and identification of a novel isoform of p21 cyclin-dependent kinase inhibitor.

Authors:  Jin Zhang; Xiangling Chen; Michael S Kent; Carlos O Rodriguez; Xinbin Chen
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

6.  The G protein-coupled receptor 87 is necessary for p53-dependent cell survival in response to genotoxic stress.

Authors:  Yanhong Zhang; Yingjuan Qian; Wenfu Lu; Xinbin Chen
Journal:  Cancer Res       Date:  2009-07-14       Impact factor: 12.701

7.  A gene signature-based approach identifies mTOR as a regulator of p73.

Authors:  Jennifer M Rosenbluth; Deborah J Mays; Maria F Pino; Luo Jia Tang; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

8.  EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1 and a worse prognosis.

Authors:  Ting-Yun Liu; Shang-Ju Wu; Mi-Hsin Huang; Fei-Yun Lo; Mong-Hsun Tsai; Ching-Hwa Tsai; Su-Ming Hsu; Chung-Wu Lin
Journal:  Mol Cancer       Date:  2010-02-09       Impact factor: 27.401

9.  Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations.

Authors:  Wensheng Yan; Gang Liu; Ariane Scoumanne; Xinbin Chen
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

10.  Identification of GRO1 as a critical determinant for mutant p53 gain of function.

Authors:  Wensheng Yan; Xinbin Chen
Journal:  J Biol Chem       Date:  2009-03-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.